Pediatric JAK Inhibitor Use and Height in Common Inflammatory Diseases
Year: 2025
Type: article
Study design: Observational Study
Abstract: This cohort study evaluates the association between Janus kinase (JAK) inhibitor use and height in pediatric patients with atopic dermatitis, juvenile idiopathic arthritis, and inflammatory bowel disease.
Source: JAMA Dermatology
Authors: Hannah L. Cole, Lisa Y. Shen, John S. Barbieri
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4415667864
